Nautilus Biotechnology, Inc.
NAUT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $211 | $374 | $224 | $438 |
| - Cash | $28 | $19 | $115 | $186 |
| + Debt | $30 | $35 | $30 | $30 |
| Enterprise Value | $214 | $389 | $140 | $282 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$6 | -$6 | -$3 | -$3 |
| % Margin | – | – | – | – |
| EBITDA | -$64 | -$74 | -$55 | -$47 |
| % Margin | – | – | – | – |
| Net Income | -$71 | -$64 | -$58 | -$50 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.56 | -0.51 | -0.46 | -0.6 |
| % Growth | -9.8% | -10.9% | 23.3% | – |
| Operating Cash Flow | -$59 | -$52 | -$46 | -$39 |
| Capital Expenditures | -$2 | -$2 | -$2 | -$2 |
| Free Cash Flow | -$61 | -$54 | -$48 | -$42 |